SOX17
SOX17 (SRY-box transcription factor 17) is a nuclear transcription regulator of the SOX family that binds target promoter DNA and helps direct embryonic development and cell fate. It is also known as transcription factor SOX-17. Browse Assay Genie's current range of SOX17 research reagents below, or read on for the biology behind the target.
SOX17 acts as a transcription regulator that binds target promoter DNA, recognising the sequences 5'-AACAAT-3' or 5'-AACAAAG-3'. It modulates transcriptional regulation via WNT3A, inhibits Wnt signalling and promotes the degradation of activated CTNNB1 (beta-catenin). According to the NCBI Gene summary, the encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins.
The SOX17 gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors, which are involved in the regulation of embryonic development and in the determination of cell fate. HGNC places it in the SRY-box transcription factors gene group. The protein is localised to the nucleus, consistent with its role in controlling gene expression. The mouse ortholog is Sox17.
Functionally, SOX17 plays a key role in the regulation of embryonic development. It is required for normal development of the definitive gut endoderm and for normal looping of the embryonic heart tube. It is important in embryonic and postnatal vascular development, including the development of arteries, and in postnatal angiogenesis, where it is functionally redundant with SOX18. SOX17 is also required for the generation and maintenance of foetal haematopoietic stem cells and for foetal haematopoiesis, and it is a probable transcriptional activator in premeiotic germ cells. Earlier HGNC names for the gene were SRY (sex determining region Y)-box 17 and SRY-box 17.
SOX17 is required for normal development of the definitive gut endoderm, making it a key factor in studies of early embryonic patterning.
SOX17 contributes to embryonic and postnatal vascular development, including arteries, and to postnatal angiogenesis alongside the functionally redundant SOX18.
SOX17 is required for generating and maintaining foetal haematopoietic stem cells and for foetal haematopoiesis.
SOX17 inhibits Wnt signalling and promotes degradation of activated CTNNB1, linking this transcription factor to control of the Wnt pathway.
SOX17 is a nuclear transcription regulator that binds target promoter DNA. It inhibits Wnt signalling, promotes degradation of activated CTNNB1 and regulates embryonic development, including gut endoderm, heart tube looping, vascular development and foetal haematopoiesis.
The HGNC approved name is SRY-box transcription factor 17, and UniProt lists the protein as transcription factor SOX-17. Previous HGNC names were SRY (sex determining region Y)-box 17 and SRY-box 17. No alternative gene symbols are recorded.
A mouse ortholog, Sox17, is recorded for the human gene. SOX17 belongs to the SOX family of SRY-related HMG-box transcription factors, which regulate embryonic development and cell fate. Check the datasheet of any product for its validated reactivity.
SOX18, other SOX family transcription factors and regulators of embryonic development and cell fate with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9H6I2; product specifications from Assay Genie datasheets.